Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
G.E.E. Boeckxstaens is a research-focused entity associated with Professor Guy Boeckxstaens, a leading expert in neurogastroenterology at KU Leuven. The entity specializes in the pathophysiology of gastrointestinal disorders, with a particular focus on neuro-immune interactions involving mast cells and the vagus nerve. Its clinical pipeline includes the development of histamine H1 receptor antagonists like ebastine for irritable bowel syndrome and mast cell stabilizers for postoperative ileus. Additionally, the entity is a pioneer in the use of vagus nerve stimulation as a therapeutic modality for intestinal inflammation and motility disorders. The work of G.E.E. Boeckxstaens bridges the gap between basic mechanistic research and clinical application, aiming to provide novel solutions for patients with functional and inflammatory gut diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on G.E.E. Boeckxstaens.